Jim Cramer Says “Cardinal Is Really the Monster” Among Drug Distributors

“The cause distributors proceed to relentlessly ascent higher. There’s nothing, you know, radical hatred the pharma middleman. Even the president doesn’t talk, like… them. But I got to archer you, their stocks, they are juggernauts. Cardinal Health, Cencora, and McKesson, they were each up much than 40% past year. Cardinal is truly the monster of that group.”

Stock marketplace information showing an upward trajectory. Photo by Burak The Weekender connected Pexels

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty cause services. The institution besides makes and distributes aesculapian and surgical products and process kits. Brown Advisory stated the pursuing regarding Cardinal Health, Inc. (NYSE:CAH) successful its 3rd 4th 2025 capitalist letter:

“Cardinal Health, Inc. (NYSE:CAH), 1 of the 3 large U.S. cause distributors, continues to payment from rising request for analyzable specialty and biologic therapies, wherever it is expanding value-added work offerings. The institution besides serves adjacent markets specified arsenic 3rd enactment logistics and the fast-growing atomic medicine space. Its aesculapian organisation concern remains an execution turnaround story, with caller absorption narrowing work gaps with peers and showing aboriginal advancement successful improving margins.”

While we admit the imaginable of CAH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.